These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 6236747

  • 1. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
    Chambers HF, Sande MA.
    Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747
    [Abstract] [Full Text] [Related]

  • 2. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    Chambers HF, Hackbarth CJ, Drake TA, Rusnak MG, Sande MA.
    J Infect Dis; 1984 Jun; 149(6):894-903. PubMed ID: 6564133
    [Abstract] [Full Text] [Related]

  • 3. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
    Fernandez-Guerrero M, Rouse M, Henry N, Wilson W.
    Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989
    [Abstract] [Full Text] [Related]

  • 4. Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus.
    Sullam PM, Täuber MG, Hackbarth CJ, Chambers HF, Scott KG, Sande MA.
    Antimicrob Agents Chemother; 1985 May; 27(5):685-7. PubMed ID: 3860185
    [Abstract] [Full Text] [Related]

  • 5. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Reddy VN, Bailey EM, Rybak MJ.
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2081-5. PubMed ID: 1963526
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureus.
    Carpenter TC, Hackbarth CJ, Chambers HF, Sande MA.
    Antimicrob Agents Chemother; 1986 Sep; 30(3):382-4. PubMed ID: 3640590
    [Abstract] [Full Text] [Related]

  • 7. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Galetto DW, Boscia JA, Kobasa WD, Kaye D.
    J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
    Madrigal AG, Basuino L, Chambers HF.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
    [Abstract] [Full Text] [Related]

  • 9. Imipenem therapy of experimental Staphylococcus epidermidis endocarditis.
    Berry AJ, Johnston JL, Archer GL.
    Antimicrob Agents Chemother; 1986 May; 29(5):748-52. PubMed ID: 3460523
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
    Chambers HF, Xiang Q, Liu, Chow LL, Hackbarth C.
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757
    [Abstract] [Full Text] [Related]

  • 11. Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.
    de Górgolas M, Avilés P, Verdejo C, Fernández Guerrero ML.
    Antimicrob Agents Chemother; 1995 Apr; 39(4):953-7. PubMed ID: 7786002
    [Abstract] [Full Text] [Related]

  • 12. Antibiotic prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.
    Archer GL, Vazquez GJ, Johnston JL.
    J Infect Dis; 1980 Nov; 142(5):725-31. PubMed ID: 7462687
    [Abstract] [Full Text] [Related]

  • 13. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics.
    Fox PM, Lampen RJ, Stumpf KS, Archer GL, Climo MW.
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2951-6. PubMed ID: 16940087
    [Abstract] [Full Text] [Related]

  • 14. Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Gilbert M, Boscia JA, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1986 Mar; 29(3):461-3. PubMed ID: 3459391
    [Abstract] [Full Text] [Related]

  • 15. [Teicoplanin versus cloxacillin, cloxacillin-gentamycin and vancomycin in the treatment of experimental endocarditis caused by methicillin-sensitive Staphylococcus aureus].
    Apellaniz G, Valdés M, Pérez R, Martín-Luengo F, García A, Soria F, Gómez J.
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):208-10. PubMed ID: 1830757
    [Abstract] [Full Text] [Related]

  • 16. Activity of teicoplanin in localized experimental infections in rats.
    Arioli V, Berti M, Candiani G.
    J Hosp Infect; 1986 Mar; 7 Suppl A():91-9. PubMed ID: 2871103
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of fleroxacin in experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ.
    Antimicrob Agents Chemother; 1989 Apr; 33(4):519-21. PubMed ID: 2499251
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditis.
    Carrizosa J, Kobasa WD, Kaye D.
    Antimicrob Agents Chemother; 1979 May; 15(5):735-7. PubMed ID: 525991
    [Abstract] [Full Text] [Related]

  • 19. Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.
    Voorn GP, Kuyvenhoven J, Goessens WH, Schmal-Bauer WC, Broeders PH, Thompson J, Michel MF.
    Antimicrob Agents Chemother; 1994 Mar; 38(3):487-93. PubMed ID: 8203842
    [Abstract] [Full Text] [Related]

  • 20. Activity of glycopeptides against Staphylococcus aureus infection in a rabbit endocarditis model: MICs do not predict in vivo efficacy.
    Asseray N, Jacqueline C, Le Mabecque V, Batard E, Bugnon D, Potel G, Caillon J.
    Antimicrob Agents Chemother; 2005 Feb; 49(2):857-9. PubMed ID: 15673789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.